Literature DB >> 7729907

Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.

L L van de Verg1, C P Mallett, H H Collins, T Larsen, C Hammack, T L Hale.   

Abstract

A murine pulmonary model was used to study the mucosal immune response to Shigella flexneri serotype 2a infection. Inoculation of BALB/cJ mice with shigellae via the intranasal route resulted in bacterial invasion of bronchial and alveolar epithelia with concomitant development of acute suppurative bronchiolitis and subsequent development of lethal pneumonia. The pathology of pulmonary lesions resembled the colitis that characterizes shigellosis in humans and primates. Significant protection against a lethal dose of S. flexneri 2a was observed in mice previously infected with two sublethal doses of the homologous strain. Immunity against lethal challenge was associated with decreased bacterial invasion of the mucosal epithelium. Over the course of two sublethal challenges, which constituted primary and secondary immunizations, mice developed pulmonary and serum immunoglobulin G and A antibody recognizing both lipopolysaccharide and invasion plasmid antigens IpaB and IpaC. Immune mice and naive control mice differed in lung lavage cytokine levels following lethal challenge. Immune mice developed significantly elevated levels of pulmonary gamma interferon within 6 h of challenge, while naive control mice developed elevated levels of this cytokine later during the initial 24-h period. Both groups had elevated levels of gamma interferon during the 24- to 48-h period of infection. Both groups also had elevated levels of tumor necrosis factor alpha within 6 h of challenge, but the control mice had significantly higher levels at the 48- and 72-h time points. Elevated levels of interleukin-4 were observed only in immunized mice. This cytokine appeared within 24 h and receded between 48 and 72 h. Fluorescence-activated cell sorter analysis of lung parenchymal cells showed that both groups experienced an initial influx of monocytes, but the proportion of this cell type began to recede in immunized mice after 48 h of infection, while peak levels were maintained in the control animals. These studies suggest that elements of local B lymphocyte activity, as well as Th1 and Th2 lymphocyte activity, may contribute to the survival of immune mice after intranasal challenge with shigellae.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729907      PMCID: PMC173248          DOI: 10.1128/iai.63.5.1947-1954.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.

Authors:  A B Hartman; L L Van de Verg; H H Collins; D B Tang; N O Bendiuk; D N Taylor; C J Powell
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 2.  Immunobiology of lymphocytes in the lung.

Authors:  J Stein-Streilein
Journal:  Reg Immunol       Date:  1988 Sep-Oct

Review 3.  Diarrhoeal disease: current concepts and future challenges. Intestinal cytokines in inflammatory bowel disease and invasive diarrhoea.

Authors:  T T MacDonald; S H Murch; S W Nicholls; E J Breese
Journal:  Trans R Soc Trop Med Hyg       Date:  1993-12       Impact factor: 2.184

4.  Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri.

Authors:  C Sasakawa; K Kamata; T Sakai; S Y Murayama; S Makino; M Yoshikawa
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

5.  Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains.

Authors:  A B Hartman; C J Powell; C L Schultz; E V Oaks; K H Eckels
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Distribution and spread of colonic lesions in shigellosis: a colonoscopic study.

Authors:  P Speelman; I Kabir; M Islam
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

7.  Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.

Authors:  S B Formal; E V Oaks; R E Olsen; M Wingfield-Eggleston; P J Snoy; J P Cogan
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

8.  Molecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping.

Authors:  J M Buysse; C K Stover; E V Oaks; M Venkatesan; D J Kopecko
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

9.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

View more
  45 in total

1.  Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species.

Authors:  Xiaotong Chen; Shyamal P Choudhari; Francisco J Martinez-Becerra; Jae Hyun Kim; Nicholas E Dickenson; Ronald T Toth; Sangeeta B Joshi; Jamie C Greenwood; John D Clements; William D Picking; C Russell Middaugh; Wendy L Picking
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Role of toll-like receptor 4 in the proinflammatory response to Vibrio cholerae O1 El tor strains deficient in production of cholera toxin and accessory toxins.

Authors:  G Kenneth Haines; Blayne Amir Sayed; Melissa S Rohrer; Verena Olivier; Karla J Fullner Satchell
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies.

Authors:  D J Philpott; J D Edgeworth; P J Sansonetti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

4.  The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.

Authors:  F C Gibson; A O Tzianabos; A B Onderdonk
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

5.  Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.

Authors:  Nadia Al-Banna; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

6.  Impact of either elevated or decreased levels of cytochrome bd expression on Shigella flexneri virulence.

Authors:  S S Way; S Sallustio; R S Magliozzo; M B Goldberg
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

7.  Identification of alkA gene related to virulence of Shigella flexneri 2a by mutational analysis.

Authors:  Zhao-Xing Shi; Heng-Liang Wang; Kun Hu; Er-Ling Feng; Xiao Yao; Guo-Fu Su; Pei-Tang Huang; Liu-Yu Huang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

8.  A novel anti-virulence gene revealed by proteomic analysis in Shigella flexneri 2a.

Authors:  Ge Zhao; Li Zhu; Erling Feng; Xiaoyu Cao; Na Shang; Xiankai Liu; Xiang Liao; Tianyi Ying; Jie Wang; Huipeng Chen; Hengliang Wang
Journal:  Proteome Sci       Date:  2010-06-12       Impact factor: 2.480

9.  Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants.

Authors:  Ryan T Ranallo; Robert W Kaminski; Tonia George; Alexis A Kordis; Qing Chen; Kathleen Szabo; Malabi M Venkatesan
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

10.  Unc119 protects from Shigella infection by inhibiting the Abl family kinases.

Authors:  Ramarao Vepachedu; Zunayet Karim; Ojas Patel; Nicholas Goplen; Rafeul Alam
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.